Detalhe da pesquisa
1.
New advances in molecular approaches to head and neck squamous cell carcinoma.
Anticancer Drugs
; 22(7): 656-64, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21178766
2.
MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling.
Life Sci Alliance
; 3(6)2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32381551
3.
STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro.
Int J Cancer
; 125(8): 1884-93, 2009 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19588483
4.
Constitutive activation of signal transducer and activator of transcription 5 contributes to tumor growth, epithelial-mesenchymal transition, and resistance to epidermal growth factor receptor targeting.
Clin Cancer Res
; 14(23): 7682-90, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19047094
5.
Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and Bcl-X(L) enhances antitumor effects in squamous cell carcinoma of the head and neck.
Mol Pharmacol
; 73(6): 1632-42, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18326051
6.
Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
Mol Pharmacol
; 73(3): 627-38, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18025070
7.
Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma.
Cancer Res
; 66(24): 11831-9, 2006 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17178880
8.
Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer.
Mol Cancer Ther
; 6(4): 1414-24, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17431120
9.
Clinical applications of gene therapy in head and neck cancer.
Curr Gene Ther
; 7(6): 446-57, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18045104
10.
In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy.
Oncogene
; 24(6): 970-9, 2005 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-15592503
11.
Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck.
J Natl Cancer Inst
; 94(5): 375-83, 2002 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-11880476
12.
Constitutive activation of Stat5b contributes to carcinogenesis in vivo.
Cancer Res
; 63(20): 6763-71, 2003 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14583472
13.
SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
Cancer Res
; 64(17): 6166-73, 2004 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15342401
14.
Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma.
Cancer Res
; 63(17): 5629-35, 2003 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14500405
15.
The degree of intratumor mutational heterogeneity varies by primary tumor sub-site.
Oncotarget
; 7(19): 27185-98, 2016 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27034009
16.
Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2.
Oncogene
; 22(23): 3608-15, 2003 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-12789269
17.
Differential function of STAT5 isoforms in head and neck cancer growth control.
Oncogene
; 21(18): 2846-53, 2002 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-11973644
18.
Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor.
Oncogene
; 22(40): 6183-93, 2003 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-13679857
19.
Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells.
Neoplasia
; 7(4): 426-31, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15967120
20.
Oligonucleotides as anticancer agents: from the benchside to the clinic and beyond.
Curr Pharm Des
; 11(22): 2825-40, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16101440